Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Samuel

Showing results (191-200 of 450) with videos related to

Pageof 45
Sort By:
Journal of Hepatology|October 10, 2018
Reply to: "Incidence of grade 3-4 liver injury under immune checkpoints inhibitors: A retrospective study"Eleonora De Martin, Jean-Marie Michot, Barbara Papouin, et al.
Journal of Hepatology|October 18, 2005
Cadaveric full-size liver transplantation and the graft alternatives in adults: a comparative study from a single centreMylène Sebagh, Funda Yilmaz, Vincent Karam, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 20, 2014
Risk factors for hepatocellular carcinoma in Caucasian patients with non-viral cirrhosis: the importance of prior obesityIsabelle Archambeaud, Hélène Auble, Pierre Nahon, et al.
Journal of Hepatology|April 19, 2017
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure, , Julia Wendon,, et al.
Transplantation|August 14, 2012
Pulmonary complications after elective liver transplantation-incidence, risk factors, and outcomeEric Levesque, Emir Hoti, Daniel Azoulay, et al.
Molecular Biology of the Cell|May 24, 2013
SHIP2 regulates epithelial cell polarity through its lipid product, which binds to Dlg1, a pathway subverted by hepatitis C virus core proteinAline Awad, Sokhavuth Sar, Ronan Barré, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 10, 2009
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statementAdrian Covic, Daniel Abramowicz, Annette Bruchfeld, et al.
Clinics and Research in Hepatology and Gastroenterology|January 10, 2020
Parvovirus B19 infection: A challenging cause of fulminant hepatitisNicolas Gille, Anne-Marie Roque-Afonso, Mylène Sebagh, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 30, 2010
Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantationPhilippe Ichai, Faouzi Saliba, Fadi Antoun, et al.
Transplantation|June 18, 2004
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantationGary Levy, Federico Villamil, Didier Samuel, et al.
Pageof 45

Showing results (191-200 of 450) with videos related to

Sort By:
Pageof 45
Journal of Hepatology|October 10, 2018
Reply to: "Incidence of grade 3-4 liver injury under immune checkpoints inhibitors: A retrospective study"Eleonora De Martin, Jean-Marie Michot, Barbara Papouin, et al.
Journal of Hepatology|October 18, 2005
Cadaveric full-size liver transplantation and the graft alternatives in adults: a comparative study from a single centreMylène Sebagh, Funda Yilmaz, Vincent Karam, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 20, 2014
Risk factors for hepatocellular carcinoma in Caucasian patients with non-viral cirrhosis: the importance of prior obesityIsabelle Archambeaud, Hélène Auble, Pierre Nahon, et al.
Journal of Hepatology|April 19, 2017
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure, , Julia Wendon,, et al.
Transplantation|August 14, 2012
Pulmonary complications after elective liver transplantation-incidence, risk factors, and outcomeEric Levesque, Emir Hoti, Daniel Azoulay, et al.
Molecular Biology of the Cell|May 24, 2013
SHIP2 regulates epithelial cell polarity through its lipid product, which binds to Dlg1, a pathway subverted by hepatitis C virus core proteinAline Awad, Sokhavuth Sar, Ronan Barré, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 10, 2009
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statementAdrian Covic, Daniel Abramowicz, Annette Bruchfeld, et al.
Clinics and Research in Hepatology and Gastroenterology|January 10, 2020
Parvovirus B19 infection: A challenging cause of fulminant hepatitisNicolas Gille, Anne-Marie Roque-Afonso, Mylène Sebagh, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 30, 2010
Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantationPhilippe Ichai, Faouzi Saliba, Fadi Antoun, et al.
Transplantation|June 18, 2004
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantationGary Levy, Federico Villamil, Didier Samuel, et al.
Pageof 45